newsfilter
← Latest News
GlobeNewswire·

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies,